Heat Biologics

NightHawk Biosciences, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.

Heat Biologics (HTBX) has announced details for a reverse stock split in order to keep shares of HTBX stock trading on the Nasdaq. The post Heat Biologics Reverse Stock Split: 10 Things for HTBX Stock Investors to Know appeared first on InvestorPlace.

Heat Biologics Reverse Stock Split: 10 Things for HTBX Stock Investors to Know

Heat Biologics boosts patents portfolio with gp96 combination award. Teleflex announces acquisition of hemostatic company Z-Medica.

Heat Biologics Provides Update, And Other News: The Good, Bad And Ugly Of Biopharma

Heat Biologics (HTBX) is in the news Thursday as HTBX stock takes a wild ride following an increasing focus on coronavirus stocks.
The post Heat Biologics News: Why HTBX Stock Is On the Move Today appeared first on InvestorPlace.

Heat Biologics News: Why HTBX Stock Is On the Move Today

AstraZeneca

BioNTech SE

GlaxoSmithKline

Inovio Pharmaceuticals

Johnson & Johnson

Moderna

Novavax

Pfizer

Sanofi

Vaxart

COVID-19 vaccine stocks have gotten slammed this month.

Has The COVID-19 Vaccine Stock Bubble Burst?

A pre-print is sending the biotech's shares higher today.

Why Heat Biologics Stock Is Popping Today

Reports of an early approval for AstraZeneca's COVID-19 vaccine are sending these three stocks lower today.

Why Heat Biologics, Inovio Pharmaceuticals, and Novavax Are Getting Clobbered Today

Encouraging early results for the biotech's coronavirus vaccine have investors excited.

Why Heat Biologics Stock Surged Today

Dynavax Technologies

Russia's surprise vaccine announcement isn't sitting well with shareholders of Dynavax, Heat Biologics, or Inovio Pharmaceuticals.

Why Dynavax Technologies, Heat Biologics, and Inovio Pharmaceuticals Are Cratering Today

Heat Biologics and Vaxart could have a lot more room to run.

2 Risky Coronavirus Vaccine Stocks That Could Make You Filthy Rich

The biotech's COVID-19 vaccine candidate hit the mark in a preclinical study.

Why Heat Biologics Stock Is Spiking Today

Heat Biologics Inc (NASDAQ: HTBX) shares are trading higher on Monday after the company announced the first patient has been treated in its first-in-human clinical trial of PTX-35.

Why Heat Biologics Stock Is Trading Higher Today

Bandwidth

Capital One

EyePoint Pharmaceuticals

Guardion Health Sciences Inc

The market is powering through its third consecutive day of massive gains. Whether the market is too optimistic has been on the minds of many, considering how unstable the economy has been this year.

Top Stocks To Short As Stock Market Surges

Brickell Biotech Inc

Digital Ally Inc

MannKind

As tensions continue to rise both domestically and internationally, taking a short position isn't a bad idea. Our deep learning algorithms have identified these 5 companies as the top stocks to short today.

Top Stocks To Short As Market Ignores Widespread Protests

News for Heat Biologics Stock (HTBX)